Navigation Links
India Main Source of Counterfeit Medicines Seized in Europe

India is the number one source of counterfeit medicines, seized in the European Union in 2006, according to EU statistics released in Brussels Thursday.

About 31 percent of all fake medicines seized in the EU last year came from India, UAE (31 percent) and China (8). The three countries are responsible for more than 70 percent of all counterfeit medicines, noted the report.

The seized fake medicines included Viagra, Cialis and Levitra but also other serious medicines such as anti-cholesterol, anti-osteoporosis or medicines to control hypertension and even painkiller Anacin tablets.

Presenting the statistics to the press in Brussels, John Taylor, head of the European Commission's counterfeit unit, said it has become very difficult to identify the country where fake goods are manufactured, as the goods will not be shipped directly to the intended market.

But since India is a significant producer of medicine, the seized counterfeit medicines are thought to be manufactured in India.

The UAE is not a producer of medicines, but the Emirate is used to hide the origin of the fake medicines and shipped from there.

John Pulford, who heads the European Commission's unit for security and specific controls, told INEPNEXT news agency that the EU is very keen to discuss the issue of fake medicines with India.

"We have a good customs cooperation with India and we are very keen to discuss the counterfeit issue with Indian officials,'' he said.

Health and safety is a big issue, as witnessed by the sizeable figures relating to seizures of pharmaceutical products, 2.5 million items compared to 500,000 items in 2005.

"The emergence of India in this sector, reflect the developing industrial capacity of this nation and highlights the reality that counterfeiting is carried out at an industrial scale where a potential profit is perceived,'' noted the EU report.

However, China remains the main source for counterfeit goods seized in Europe , with over 80 percent all articles seized coming from there.

In 2006, customs officials in the EU seized more than 250 million counterfeit goods in 2006 compared with 75 million in 2005, an increase of 330 percent, at its external borders.

Medicines, cigarettes and other goods that can seriously damage the health of consumers continue to be faked in large quantities.

Changes in the routes used by criminals to trade in fake goods, the use of the internet and the transport of small quantities by air or postal traffic make customs job even more challenging.

The 2006 statistics show an increase in almost all sectors of goods. In the sector of electronic equipment there has been an increase, particularly in relation to the violation of the patent on MP3/MP4 players and other electronic equipment such as DVD players.

More than 60 percent of the articles seized in 2006 in the EU were cigarettes.

In the food sector Turkey remains the main source and in the electrical equipment sector Malaysia has become the main source.

Nearly half of the fake goods were seized in Germany because a lot of shipment, especially from China, arrives at the Hamburg port.

An estimated $200 billion worth of counterfeit goods are floating around the world.

Close cooperation between customs in the EU has inevitably played a role in the increase in seizures made during 2006.

A good example of the fruitful results of this cooperation is the successful outcome of an operation carried out in September 2006. A total of 92 containers were seized, containing a wide range of products including fake toys, sunglasses, shoes and imitation car parts.

"Counterfeiting continues to constitute a dangerous threat for our health, safety and the economy" warned EU Taxation and Customs Commissioner Laszlo Kovacs.

"International customs cooperation with our major trading partners, in particular China and India needs to be further implemented," said the Commissioner.


'"/>




Related medicine news :

1. Is Diabetes the Leading Cause of Kidney Failure in India
2. AIDS Disaster in India is Imminent
3. Indian Prime Minister has successful Knee Replacement Surgery
4. International community warns India on HIV situation
5. India takes on foot-and-mouth disease by vaccinating animals
6. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
7. India to benefit from pharma companies move
8. Healthcare sector is now a multi billion-dollar industry in India
9. The World Bank funds private Hospital in India
10. Parke-Davis (India) runs into rough weather – Court orders attachment of asset
11. Indian Doctor granted US patent on organ regeneration
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2017)... ... May 26, 2017 , ... ... CareFusion NOX-T3 portable sleep monitor with its Somnoware Sleep Device Interface (SDI). Somnoware ... for diagnostic device operations. With this platform, initializing devices and importing studies are ...
(Date:5/26/2017)... Sparks, Nevada (PRWEB) , ... May 26, 2017 ... ... to produce the first ever copper, antimicrobial, mesh back 24/7 task chair specifically ... and conference applications. “We are thrilled to partner with Cupron® to provide ...
(Date:5/26/2017)... Texas (PRWEB) , ... May 26, 2017 , ... Yisrayl ... a new publication this week that is focusing on the Peace Agreements being discussed ... his Middle East sprint in a race to try to speed up peace talks ...
(Date:5/26/2017)... Francisco, CA (PRWEB) , ... May 26, 2017 , ... ... Francisco, is proud to announce a new, informational blog post on insurance options. If ... surgery, checking insurance plans may help save time and money. Visiting an in-network provider ...
(Date:5/26/2017)... ... 26, 2017 , ... Centennial-based BluSky Restoration Contractors announced that ... Annual Clays for Kids fundraiser, to be held Friday, Sept. 22, at Kiowa ... part of BluSky’s partnership with The Adoption Exchange, BluSky will also share sponsorship ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)...  Two Bayer U.S. Pharmaceutical leaders received top awards ... 28 th Woman of the Year ... longstanding mission of furthering the advancement and impact of ... Cindy Powell-Steffen , senior director of brand activation and ... Libby Howe , a regional business manager for New ...
(Date:5/15/2017)... Inc., a privately-held CNS pharmaceutical company based in ... disease (PD), has enrolled the first patient in the RASMET ... study involving patients with PD and taking place at 12 ... period. The first stage is open label and involves single ... Denver , Boca Raton ...
(Date:5/10/2017)... Inc. (Nasdaq: HOLX ) announced today the ... April 1, 2017 .   GAAP diluted earnings per ... prior year period as the sale of the blood ... diluted EPS of $0.50 increased 6.4%.  Revenue of $715.4 ... Excluding the effects of blood screening and the acquired ...
Breaking Medicine Technology: